Premium
Efficacy of clozapine in a non‐schizophrenic patient with psychogenic polydipsia and central pontine myelinolysis
Author(s) -
Mauri M. C.,
Volonteri L. S.,
Fiorentini A.,
Dieci M.,
Righini A.,
Vita A.
Publication year - 2002
Publication title -
human psychopharmacology: clinical and experimental
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.461
H-Index - 78
eISSN - 1099-1077
pISSN - 0885-6222
DOI - 10.1002/hup.407
Subject(s) - polydipsia , clozapine , central pontine myelinolysis , psychogenic disease , medicine , schizophrenia (object oriented programming) , psychology , atypical antipsychotic , antipsychotic , pediatrics , psychiatry , hyponatremia , endocrinology , diabetes mellitus
Clozapine is an atypical antipsychotic drug that has been demonstrated to be a highly effective treatment for polydipsia in schizophrenic patients. The authors report the first case of a non‐schizophrenic patient affected by polydipsia and central pontine myelinolysis who was successfully treated with clozapine. Copyright © 2002 John Wiley & Sons, Ltd.